Alloy vs OlleveCare
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
OlleveCare
Best for Maryland, DC, Virginia, and other listed-state buyers who want a small one-stop virtual-care storefront for GLP-1 weight loss combined with virtual urgent care and non-controlled refills, and who are comfortable starting a booking flow on IntakeQ without seeing pricing upfront. Acceptable fit only for buyers who already trust a Maryland-area solo virtual-care practice and prioritize the bundled urgent-care + GLP-1 model. NOT for buyers who require named-pharmacy disclosure, named medical director credentials, LegitScript verification, itemized dose-ladder pricing pre-purchase, defined refund terms, or any independent trust-signal verification — those buyers should look at WLR providers with explicit pharmacy/network disclosure (e.g., AVARA Rx with DiRx Health + Beluga Health, or Henry/Mochi/Found with disclosed clinical operations).Side-by-Side Comparison
| Feature | Alloy | OlleveCare |
|---|---|---|
| Overall Score | ✓7.4/10 | 4.2/10 |
| Starting Price | $80/mo | — |
| Editorial Rating | ✓3.7 ★ /5 | 2.1 ★ /5 |
| Features | 8 features | ✓10 features |
| States Available | 0 | ✓13 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
OlleveCare
Pros
- ✓13-state availability is enumerated verbatim on the homepage FAQ (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID) — more transparent than DTC peers that say 'nationwide' without listing states
- ✓Both semaglutide and tirzepatide options surfaced for GLP-1 weight loss — buyers can switch molecules without switching platforms
- ✓Multi-service platform — GLP-1 + virtual urgent care + non-controlled refills lets a buyer consolidate primary-care-adjacent needs with one provider
- ✓Cash-pay with superbill option preserves the patient's ability to submit for out-of-network reimbursement
- ✓Founder/operator (Ahmed Emam) is identified by name in the footer linking to a personal Linktree — slightly above the fully-anonymous WordPress-storefront floor
- ✓Cancellation policy is disclosed: appointments canceled less than one hour before the visit or no-shows may incur a 'pre-disclosed non-refundable fee'
Cons
- ✗Operating legal entity name (LLC / PLLC / PA / Inc suffix) NOT disclosed anywhere on the site — only the brand 'OlleveCare' and individual operator 'Ahmed Emam' surface. Buyers cannot verify the legal entity in any state corporation registry.
- ✗Pricing NOT disclosed pre-booking — FAQ explicitly says 'You'll see the fee at the time of booking,' requiring the buyer to enter the IntakeQ flow before knowing the cost. No dose-ladder pricing for semaglutide (0.25mg/0.5mg/1mg/1.7mg/2.4mg) or tirzepatide (2.5mg/5mg/7.5mg/10mg/12.5mg/15mg).
- ✗Pharmacy partner NOT named — FAQ says 'prescriptions sent to your preferred pharmacy,' suggesting a fill-at-retail model rather than a named 503A compounding partnership. Buyers cannot verify the dispensing pharmacy's licensure or 503A/503B status.
- ✗Medical director / named prescribing clinician NOT disclosed by name. Only generic 'board-certified providers' and '10+ years of experience' language surfaces. MD/DO/NP/PA credential breakdown NOT specified.
- ✗LegitScript verification badge NOT displayed. BBB profile NOT found for OlleveCare or Gilead Express. SOC 2 and HIPAA-attestation seals NOT displayed.
- ✗Site is a single-page WordPress/Pagelayer/LiteSpeed build — /pricing, /about, /how-it-works, /faq, /services, /medical-weight-loss all return HTTP 404 (anchor-link nav only, no discrete pages). Suggests a small / early-stage operation rather than an established platform.
- ✗Lab-work requirements NOT specified — FAQ verbatim: 'If lab work is required, your provider will direct you on how to go about completing them,' with no baseline-labs-required, no Quest/Labcorp partnership, no panel disclosure.
- ✗Refund policy NOT surfaced beyond the late-cancellation fee — no medication-return policy, no provider-disqualifies refund, no satisfaction guarantee.
- ✗Branded GLP-1 options (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Rybelsus) NOT confirmed — semaglutide and tirzepatide are listed as molecules but the homepage does not clarify whether branded products are available or whether the model is compounded-only.
- ✗Form-factor breakdown NOT confirmed — injection is implied for semaglutide/tirzepatide but ODT, sublingual, troche, and oral options NOT confirmed.
Our Verdict
Alloy edges out OlleveCare with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. OlleveCare remains a solid alternative, especially if you're looking for Maryland, DC, Virginia, and other listed-state buyers who want a small one-stop virtual-care storefront for GLP-1 weight loss combined with virtual urgent care and non-controlled refills, and who are comfortable starting a booking flow on IntakeQ without seeing pricing upfront. Acceptable fit only for buyers who already trust a Maryland-area solo virtual-care practice and prioritize the bundled urgent-care + GLP-1 model. NOT for buyers who require named-pharmacy disclosure, named medical director credentials, LegitScript verification, itemized dose-ladder pricing pre-purchase, defined refund terms, or any independent trust-signal verification — those buyers should look at WLR providers with explicit pharmacy/network disclosure (e.g., AVARA Rx with DiRx Health + Beluga Health, or Henry/Mochi/Found with disclosed clinical operations)..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Alloy and OlleveCare head-to-heads in the same category.
- Alloy vs CoreAge Rx
- Alloy vs TrimRx
- Alloy vs Amazon One Medical
- OlleveCare vs NovoCare Pharmacy
- OlleveCare vs Vytora Health
- OlleveCare vs Enhance MD
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.